Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary care

Atrial fibrillation (AF) is an important risk factor for thromboembolic events, and anticoagulation therapy can reduce this risk. Vitamin K antagonists (VKAs), such as warfarin, have been used for decades in patients with AF for stroke prevention. Currently, non-VKA oral anticoagulants (NOACs) are a...

Descripción completa

Detalles Bibliográficos
Autores principales: Guimarães, Patrícia O, Kaatz, Scott, Lopes, Renato D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567236/
https://www.ncbi.nlm.nih.gov/pubmed/26379443
http://dx.doi.org/10.2147/IJGM.S62760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567236/
https://www.ncbi.nlm.nih.gov/pubmed/26379443
http://dx.doi.org/10.2147/IJGM.S62760

Ejemplares similares